Clorox is committed to helping combat the spread of HAIs by offering healthcare tactics to meet your infection prevention needs — excellent product efficacy, expert knowledge, and training.
There are at least 19 different strains of Acinetobacter, but according to the CDC Acinetobacter baumannii accounts for 80% of Acinetobacter infections. Acinetobacter is a significant public health concern because it is a resilient, opportunistic pathogen which is genetically capable of quickly developing multi-drug resistance. Prevention is the best option!
Acinetobacter is a genus of aerobic, Gram-negative bacteria widely distributed in the environment (soil, water, air, food sources, environmental surfaces and people's skin). Acinetobacter is harmless to most healthy people. However, critically ill people, patients in intensive care units and those with weakened immune systems, chronic lung disease or diabetes – or those on catheters or ventilators – are at a higher risk.
Acinetobacter can be transmitted via contaminated hands, environmental surfaces, ventilators, tubing and other medical equipment. The risk of spreading and contamination is high because it can survive on environmental surfaces for extended periods of time – an average of 27 days in healthcare settings – with the potential to survive up to three years!
Acinetobacter can infect a variety of sites (skin, tissue, central nervous system, bone, respiratory tract, urinary tract and bloodstream); however, the skin and airways of critically ill patients are primary targets. Typically, Acinetobacter causes nosocomial pneumonia and wound or blood infections. Fever, chills and cough are common symptoms.
The proper use of an EPA-registered disinfectant with proven efficacy for Acinetobacter can reduce the risk of transmission.
Learn more about Acinetobacter baumannii at www.cdc.gov.
For all healthcare-related questions and orders, please email us at healthcare@clorox.com or call 1-800-234-7700.
Products that kill Acinetobacter
Email
Print